Chiron Capital Management’s Zimmer Biomet ZBH Stock Holding History

Chiron Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Buy	2,400 +160	+7%	+$14K	0.19%	128
2026 Q1	$203K	Buy	+2,240	New	+$206K	0.21%	110
2025 Q3	$201K	Buy	+2,040	New	+$202K	0.17%	118
2025 Q2	–	Sell	-2,440	Closed	-$276K	–	125
2025 Q1	$276K	Hold	2,440	–	–	0.25%	89
2024 Q4	$258K	Sell	2,440 -100	-4%	-$10.7K	0.24%	92
2024 Q3	$274K	Buy	2,540 +100	+4%	+$10.9K	0.24%	92
2024 Q2	$265K	Buy	+2,440	New	+$288K	0.25%	92
2023 Q3	–	Sell	-1,740	Closed	-$253K	–	130
2023 Q2	$253K	Sell	1,740 -2,400	-58%	-$326K	0.2%	89
2023 Q1	$535K	Sell	4,140 -3,700	-47%	-$465K	0.37%	59
2022 Q4	$1,000K	Sell	7,840 -1,600	-17%	-$186K	0.7%	32
2022 Q3	$987K	Buy	9,440 +300	+3%	+$32.9K	0.66%	30
2022 Q2	$960K	Buy	9,140 +600	+7%	+$71.2K	0.61%	37
2022 Q1	$1.09M	Buy	8,540 +2,937	+52%	+$354K	0.69%	32
2021 Q4	$691K	Buy	5,603 +4,017	+253%	+$526K	0.5%	49
2021 Q3	$225K	Buy	+1,586	New	+$233K	0.16%	90
2020 Q4	–	Sell	-41	Closed	-$5K	–	458
2020 Q3	$5K	Buy	+41	New	+$5.36K	﹤0.01%	376

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Chiron Capital Management's ZBH Position: Q2 2026 in Review

Chiron Capital Management increased its Zimmer Biomet (ZBH) stake by 7.1% in Q2 2026, buying an estimated $14K and bringing the position to 2,400 shares worth $207K. The position accounts for 0.19% of the portfolio, ranked #128.

Chiron Capital Management first reported a position in ZBH in Q3 2020 and has held it in 16 quarters since. The position peaked at $1.09M in Q1 2022. 160 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Chiron Capital Management held 2,400 shares of Zimmer Biomet worth $207K as of Q2 2026.
Chiron Capital Management bought 160 Zimmer Biomet shares in Q2 2026, an estimated $14K.
Zimmer Biomet made up 0.19% of Chiron Capital Management's portfolio in Q2 2026, its #128 holding.
Chiron Capital Management first reported a position in Zimmer Biomet in Q3 2020 and has held it in 16 quarters since.
Chiron Capital Management's Zimmer Biomet position peaked at $1.09M in Q1 2022.
160 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.